A leader in the development of RNA based therapeutics has engaged The Leyden Group associates to identify the company’s lead in the Pathology (Anatomic & Clinical) function within their Preclinical Safety Assessment group. The company has multiple therapeutics on the market and a deep pipeline of promising drugs across a variety of disease targets.
The person hired for this role will be an ACVP Boarded pathologist, with several years of experience in the pharmaceutical industry. A strong research background and experience in regulatory agency interactions/submissions is also required.
The Executive Director will scientifically lead all scientific efforts within the pathology function, be deeply involved on preclinical regulatory strategy teams and supervise two ACVP pathologists. A pathologist with previous management experience is strongly desired.
The position reports to the company’s Senior Vice President of Preclinical Safety and will be based at the company’s California headquarters.